<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Chai JH</submitter><pubmed_abstract>Historically, diabetes is diagnosed by measuring fasting (FPG) and two-hour post oral glucose load (OGTT) plasma concentration and interpreting it against recommended clinical thresholds of the patient. More recently, glycated haemoglobin A1c (HbA1c) has been included as a diagnostic criterion. Within-individual biological variation (CVi), analytical variation (CVa) and analytical bias of a test can impact on the accuracy and reproducibility of the classification of a disease. A test with large biological and analytical variation increases the likelihood of erroneous classification of the underlying disease state of a patient. Through numerical simulations based on the laboratory results generated from a large population health survey, we examined the impact of CVi, CVa and bias on the cla</pubmed_abstract><journal>Scientific reports</journal><pagination>13721</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5651837</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of analytical and biological variations on classification of diabetes using fasting plasma glucose, oral glucose tolerance test and HbA1c.</pubmed_title><pmcid>PMC5651837</pmcid><pubmed_authors>Chai JH</pubmed_authors><pubmed_authors>Toh SA</pubmed_authors><pubmed_authors>Ma S</pubmed_authors><pubmed_authors>Heng D</pubmed_authors><pubmed_authors>Yoong J</pubmed_authors><pubmed_authors>Lim WY</pubmed_authors><pubmed_authors>Loh TP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of analytical and biological variations on classification of diabetes using fasting plasma glucose, oral glucose tolerance test and HbA1c.</name><description>Historically, diabetes is diagnosed by measuring fasting (FPG) and two-hour post oral glucose load (OGTT) plasma concentration and interpreting it against recommended clinical thresholds of the patient. More recently, glycated haemoglobin A1c (HbA1c) has been included as a diagnostic criterion. Within-individual biological variation (CVi), analytical variation (CVa) and analytical bias of a test can impact on the accuracy and reproducibility of the classification of a disease. A test with large biological and analytical variation increases the likelihood of erroneous classification of the underlying disease state of a patient. Through numerical simulations based on the laboratory results generated from a large population health survey, we examined the impact of CVi, CVa and bias on the cla</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2026-05-05T23:29:20.822Z</modification><creation>2019-03-27T02:59:37Z</creation></dates><accession>S-EPMC5651837</accession><cross_references><pubmed>29057963</pubmed><doi>10.1038/s41598-017-14172-8</doi></cross_references></HashMap>